Health Care & Life Sciences » Healthcare Provision | Polski Bank Komorek Macierzystych

Polski Bank Komorek Macierzystych S.A. | Income Statement

Fiscal year is January-December. All values PLN Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
72,120.50
85,026.30
104,816.20
128,779.90
148,867.80
161,642.30
Cost of Goods Sold (COGS) incl. D&A
54,099.30
61,327.70
81,196.20
89,716.90
97,947.10
119,699.70
Gross Income
18,021.10
23,698.60
23,619.90
39,063.00
50,920.70
41,942.60
SG&A Expense
6,336.50
7,366.40
7,420.40
8,019.90
11,506.80
10,808.30
EBIT
10,239.10
14,939.40
14,681.00
-
38,083.20
41,315.40
Unusual Expense
714.80
3,772.10
-
-
246.90
220.30
Non Operating Income/Expense
523.10
150.80
733.20
496.30
1,635.60
346.10
Interest Expense
334.80
340.70
276.30
652.30
1,631.50
944.80
Pretax Income
10,021.60
11,247.80
15,318.90
28,876.40
38,368.80
41,841.50
Income Tax
2,029.70
1,359.70
6,208.40
5,291.10
8,498.50
7,469
Consolidated Net Income
7,991.90
9,888.20
9,110.50
23,585.30
29,870.30
34,372.60
Net Income
7,937.50
9,365.50
8,699.60
21,829.20
29,334.30
34,686.90
Net Income After Extraordinaries
7,937.50
9,365.50
8,699.60
21,829.20
29,334.30
34,686.90
Net Income Available to Common
7,937.50
9,365.50
8,699.60
21,829.20
29,334.30
34,686.90
EPS (Basic)
344.93
406.42
1.86
4.61
6.20
6.10
Basic Shares Outstanding
23.00
23.00
4,682.00
4,734.80
4,734.80
5,681.80
EPS (Diluted)
344.93
406.42
1.86
4.61
6.20
6.10
Diluted Shares Outstanding
23.00
23.00
4,682.00
4,734.80
4,734.80
5,681.80
EBITDA
13,229.50
18,187.50
19,217.60
34,739.10
43,365.30
47,751.80
Other Operating Expense
1,445.50
1,392.80
1,518.50
1,110.20
1,330.70
10,181
Non-Operating Interest Income
309.10
270.40
181.00
92.10
34.60
16.40
Minority Interest Expense
54.50
522.60
410.90
1,756.10
536.00
314.30

About Polski Bank Komorek Macierzystych

View Profile
Address
ul. Jana Pawla II 29
Warsaw MZ 00
Poland
Employees -
Website http://www.pbkm.pl
Updated 07/08/2019
Polski Bank Komorek Macierzystych SA engages in the provision of umbilical cord blood collection services. It also provides cord blood stem cells transplantation. It operates through the Strategic Market and Other Markets segments.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.